SI1196410T1 - Respiratory syncytial virus replication inhibitors - Google Patents

Respiratory syncytial virus replication inhibitors

Info

Publication number
SI1196410T1
SI1196410T1 SI200030358T SI200030358T SI1196410T1 SI 1196410 T1 SI1196410 T1 SI 1196410T1 SI 200030358 T SI200030358 T SI 200030358T SI 200030358 T SI200030358 T SI 200030358T SI 1196410 T1 SI1196410 T1 SI 1196410T1
Authority
SI
Slovenia
Prior art keywords
respiratory syncytial
syncytial virus
virus replication
replication inhibitors
inhibitors
Prior art date
Application number
SI200030358T
Other languages
English (en)
Slovenian (sl)
Inventor
Frans Eduard Janssens
Jean Fernand Armand Janssen-Cilag S.A. LACRAMPE
Jerome Emile G. Janssen-Cilag S.A. GUILLEMONT
Marc Gaston Janssen-Cilag S.A. VENET
Koenraad Jozef Lodewijk Marcel Andries
Original Assignee
Janssen Pharmaceutica N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica N.V. filed Critical Janssen Pharmaceutica N.V.
Publication of SI1196410T1 publication Critical patent/SI1196410T1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
SI200030358T 1999-06-28 2000-06-20 Respiratory syncytial virus replication inhibitors SI1196410T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP99202089 1999-06-28
PCT/EP2000/005677 WO2001000615A1 (en) 1999-06-28 2000-06-20 Respiratory syncytial virus replication inhibitors
EP00936899A EP1196410B1 (en) 1999-06-28 2000-06-20 Respiratory syncytial virus replication inhibitors

Publications (1)

Publication Number Publication Date
SI1196410T1 true SI1196410T1 (en) 2004-08-31

Family

ID=8240374

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200030358T SI1196410T1 (en) 1999-06-28 2000-06-20 Respiratory syncytial virus replication inhibitors

Country Status (34)

Country Link
US (2) US7071192B1 (cs)
EP (2) EP1400519B1 (cs)
JP (1) JP2003503403A (cs)
KR (1) KR100731273B1 (cs)
CN (1) CN1171887C (cs)
AR (1) AR024495A1 (cs)
AT (2) ATE259796T1 (cs)
AU (1) AU774829B2 (cs)
BG (1) BG65373B1 (cs)
BR (1) BR0011997A (cs)
CA (1) CA2376785A1 (cs)
CZ (1) CZ20014573A3 (cs)
DE (2) DE60033859T2 (cs)
DK (1) DK1196410T3 (cs)
EA (1) EA004746B1 (cs)
EE (1) EE04592B1 (cs)
ES (2) ES2283716T3 (cs)
HK (1) HK1045998B (cs)
HR (2) HRP20010934A2 (cs)
HU (1) HUP0201789A3 (cs)
IL (2) IL147328A0 (cs)
MX (1) MXPA02000117A (cs)
MY (1) MY129810A (cs)
NO (1) NO321599B1 (cs)
NZ (1) NZ515392A (cs)
PL (1) PL200694B1 (cs)
PT (1) PT1196410E (cs)
SI (1) SI1196410T1 (cs)
SK (1) SK18952001A3 (cs)
TR (2) TR200103805T2 (cs)
TW (1) TWI267513B (cs)
UA (1) UA75866C2 (cs)
WO (1) WO2001000615A1 (cs)
ZA (1) ZA200110473B (cs)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6495580B1 (en) 1998-01-29 2002-12-17 Viropharma Incorporated Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases
US20040010004A1 (en) 2000-01-17 2004-01-15 Naoki Tsuchiya Benzimidazole derivatives
WO2000003997A1 (fr) 1998-07-15 2000-01-27 Teijin Limited Derives de thiobenzimidazole
IL150565A0 (en) * 2000-01-17 2003-02-12 Teijin Ltd Benzimidazole derivatives and pharmaceutical compositions containing the same
US6489338B2 (en) 2000-06-13 2002-12-03 Bristol-Myers Squibb Company Imidazopyridine and imidazopyrimidine antiviral agents
US6506738B1 (en) 2000-09-27 2003-01-14 Bristol-Myers Squibb Company Benzimidazolone antiviral agents
ATE301653T1 (de) 2000-12-15 2005-08-15 Glaxo Group Ltd Pyrazolopyridine
JP2004515550A (ja) 2000-12-15 2004-05-27 グラクソ グループ リミテッド 治療用化合物
US6774134B2 (en) 2000-12-20 2004-08-10 Bristol-Myers Squibb Company Heterocyclic substituted 2-methyl-benzimidazole antiviral agents
JP2004529119A (ja) 2001-03-08 2004-09-24 スミスクライン ビーチャム コーポレーション ピラゾロピリジン誘導体
EP1372643A1 (en) 2001-03-30 2004-01-02 Smithkline Beecham Corporation Pyrazolopyridines, process for their preparation and use as therapeutic compounds
DE60212949T2 (de) 2001-04-10 2007-01-04 Smithkline Beecham Corp. Antivirale pyrazolopyridin verbindungen
WO2002088124A2 (en) 2001-04-27 2002-11-07 Smithkline Beecham Corporation Pyrazolo'1,5-a!pyridine derivatives
US7030150B2 (en) 2001-05-11 2006-04-18 Trimeris, Inc. Benzimidazole compounds and antiviral uses thereof
US7186714B2 (en) 2001-06-21 2007-03-06 Smithkline Beecham Corporation Imidazo[1,2-α]pyridine derivatives for the prophylaxis and treatment of herpes viral infections
ES2262893T3 (es) * 2001-10-05 2006-12-01 Smithkline Beecham Corporation Derivados de imidazo-piridina para su uso en el tratamiento de infeccion virica por herpes.
US6919331B2 (en) 2001-12-10 2005-07-19 Bristol-Myers Squibb Company Substituted 2-methyl-benzimidazole respiratory syncytial virus antiviral agents
DE60222465T2 (de) 2001-12-11 2008-06-05 Smithkline Beecham Corp. Pyrazolopyridin-derivate als antiherpesmittel
US7244847B2 (en) * 2002-02-06 2007-07-17 Isis Pharmaceuticals, Inc. Benzimidazole compounds
WO2004014317A2 (en) 2002-08-09 2004-02-19 Viropharma Incorporated Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases
CA2495266A1 (en) 2002-08-09 2004-02-19 Viropharma Incorporated Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases
US7153863B2 (en) 2002-10-03 2006-12-26 Smithkline Beecham Corporation Therapeutic compounds based on pyrazolopyridline derivatives
WO2005042530A1 (en) 2003-10-30 2005-05-12 Boehringer Ingelheim (Canada) Ltd. Rsv polymerase inhibitors
AR046972A1 (es) * 2003-12-18 2006-01-04 Tibotec Pharm Ltd Derivados de los amino-bencimidazoles como inhibidores de la replicacion del virus sincitial respiratorio
BRPI0417668A (pt) 2003-12-18 2007-04-03 Tibotec Pharm Ltd derivados de piperidina-amino-benzimidazol como inibidores de replicação do vìrus sincicial respiratório
ES2328700T3 (es) * 2003-12-18 2009-11-17 Tibotec Pharmaceuticals Ltd. Aminobenzimidazoles y benzimidazoles como inhibidores de la replicacion del virus respiratorio sincital.
AR046959A1 (es) * 2003-12-18 2006-01-04 Tibotec Pharm Ltd Morfolinilo que contiene bencimidazoles como inhibidores de la replicacion del virus sincitial respiratorio
KR101123055B1 (ko) * 2003-12-18 2012-04-12 티보텍 파마슈티컬즈 호흡기 세포융합 바이러스 복제의 억제제인 5- 또는 6-치환벤지미다졸 유도체
MXPA06007110A (es) * 2003-12-18 2006-08-23 Tibotec Pharm Ltd Derivados de los amino-bencimidazoles como inhibidores de la replicacion del virus sincitial respiratorio.
CN101142208B (zh) * 2005-03-17 2012-05-23 泰博特克药品有限公司 作为呼吸道合胞病毒复制抑制剂的1,3-二氢-苯并咪唑-2-亚基胺
EP1896473B1 (en) 2005-06-20 2011-10-19 Tibotec Pharmaceuticals 1-[[2-amino-3-(substituted alkyl)-3h-benzimidazolyl]methyl]-3-subtituted-1,3-dihydro-benzoimidazol-2-ones as inhibitors of respiratory syncytial virus replication
CN101203506B (zh) * 2005-06-20 2012-02-22 泰博特克药品有限公司 杂环基氨基烷基取代的苯并咪唑
CL2008001003A1 (es) 2007-04-11 2008-10-17 Actelion Pharmaceuticals Ltd Compuestos derivados de oxazolidinona; composicion farmaceutica que comprende a dichos compuestos; y su uso para preparar un medicamento para tratar una infeccion bacteriana.
US20110190336A1 (en) * 2008-10-16 2011-08-04 Cara Therapeutics, Inc. Azabenzimidazolones
JP5487692B2 (ja) 2009-04-10 2014-05-07 国立大学法人京都大学 複素環骨格を有する化合物および該化合物を不斉触媒として用いる光学活性化合物の製造方法
US8993604B2 (en) 2009-06-30 2015-03-31 Siga Technologies, Inc. Treatment and prevention of dengue virus infections
CA2763194A1 (en) * 2009-06-30 2011-01-06 Siga Technologies, Inc. Treatment and prevention of dengue virus infections
CA2841906A1 (en) 2011-07-15 2013-01-24 Shionogi & Co., Ltd. Azabenzimidazole derivative having ampk-activating activity
WO2014031784A1 (en) * 2012-08-23 2014-02-27 Alios Biopharma, Inc. Compounds for the treatment of paramoxyvirus viral infections
JP2016079168A (ja) 2014-10-17 2016-05-16 塩野義製薬株式会社 9員縮合環誘導体

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1140119A (en) * 1978-04-03 1983-01-25 Joseph Torremans N-heterocyclyl-4-piperidinamines
US4556660A (en) 1982-07-12 1985-12-03 Janssen Pharmaceutica N.V. N-(Bicyclic heterocyclyl)-4-piperidinamines
US4634704A (en) 1983-10-06 1987-01-06 Janssen Pharmaceutica, N.V. Anti-allergic five membered heterocyclic ring containing N-(bicyclic heterocycyl)-4-piperidinamines
US4695569A (en) 1983-11-30 1987-09-22 Janssen Pharmaceutica N.V. Bicyclic heterocyclyl containing N-(bicyclic heterocyclyl)-4-piperidinamines
EP0144101B1 (en) 1983-11-30 1991-02-06 Janssen Pharmaceutica N.V. Bicyclic heterocyclyl containing n-(bicyclic heterocyclyl)-4-piperidinamines
PH23995A (en) 1984-01-09 1990-02-09 Janssen Pharmaceutica Nv 4((bicycle heterocyclyl)-methyl and hetero)piperidines
US4588722A (en) 1984-01-09 1986-05-13 Janssen Pharmaceutica N.V. N-(4-piperidinyl) bicyclic condensed 2-imidazolamine derivatives
EP0232937B1 (en) 1986-02-03 1992-08-19 Janssen Pharmaceutica N.V. Anti-histaminic compositions containing n-heterocyclyl-4-piperidinamines
US4897401A (en) 1987-06-19 1990-01-30 Janssen Pharmaceutical N.V. N-(4-piperidinyl) bicyclic condensed 2-imidazolamine derivatives useful in treating allergic diseases
CA1317939C (en) 1987-07-01 1993-05-18 Janssen Pharmaceutica Naamloze Vennootschap ¬(bicyclic heterocyclyl)methyl and -hetero| substituted hexahydro-1h-azepines and pyrrolidines
GB8716313D0 (en) * 1987-07-10 1987-08-19 Janssen Pharmaceutica Nv 2-(heterocyclylalkyl)imidazopyridines
US5597824A (en) 1987-11-03 1997-01-28 Abbott Laboratories Analogs of oxetanyl purines and pyrimidines
IE904378A1 (en) 1989-12-20 1991-07-03 Abbott Lab Analogs of oxetanyl purines and pyrimidines
NZ238863A (en) 1990-07-19 1993-03-26 Janssen Pharmaceutica Nv Substituted thiazolyl and pyridinyl derivatives
KR100190299B1 (ko) 1990-07-19 1999-06-01 디르크 반테 신규한 옥사졸릴 유도체
US5567824A (en) 1994-05-24 1996-10-22 Merck & Co., Inc. Palladium catalyzed ring closure of triazolyltryptamine
US5693661A (en) * 1995-06-07 1997-12-02 Eli Lilly And Company Anti-viral compounds
PE107598A1 (es) * 1996-09-11 1999-01-29 Ucb Sa Cetirizina util para el tratamiento de enfermedades de tipo virico
WO1998031363A1 (en) * 1997-01-22 1998-07-23 Eli Lilly And Company Anti-viral compounds
EP1001767A4 (en) * 1997-06-04 2001-07-04 Lilly Co Eli ANTIVIRAL CONNECTIONS
BR9907951A (pt) 1998-03-06 2001-01-30 Janssen Pharmaceutica Nv Inibidores de transporte de glicina
CA2338147A1 (en) * 1998-07-20 2000-02-03 Kuo-Long Yu Substituted benzimidazole antiviral agents

Also Published As

Publication number Publication date
ZA200110473B (en) 2003-03-20
NZ515392A (en) 2004-03-26
CZ20014573A3 (cs) 2002-05-15
TR200103805T2 (tr) 2002-06-21
NO321599B1 (no) 2006-06-06
EP1400519B1 (en) 2007-03-07
DE60008382D1 (en) 2004-03-25
WO2001000615A8 (en) 2002-01-10
BR0011997A (pt) 2002-03-05
US20060058309A1 (en) 2006-03-16
CA2376785A1 (en) 2001-01-04
DE60033859T2 (de) 2007-11-08
US7071192B1 (en) 2006-07-04
ATE356121T1 (de) 2007-03-15
EP1196410B1 (en) 2004-02-18
EA004746B1 (ru) 2004-08-26
NO20016370D0 (no) 2001-12-27
HRP20010934A2 (en) 2003-06-30
ES2283716T3 (es) 2007-11-01
TWI267513B (en) 2006-12-01
DE60008382T2 (de) 2004-12-02
PT1196410E (pt) 2004-07-30
AR024495A1 (es) 2002-10-02
ATE259796T1 (de) 2004-03-15
KR100731273B1 (ko) 2007-06-21
HK1045998B (zh) 2005-06-03
MY129810A (en) 2007-05-31
EE200100694A (et) 2003-02-17
UA75866C2 (en) 2006-06-15
DK1196410T3 (da) 2004-06-28
DE60033859D1 (de) 2007-04-19
SK18952001A3 (sk) 2002-11-06
EA200200086A1 (ru) 2002-06-27
HUP0201789A2 (hu) 2002-11-28
BG65373B1 (bg) 2008-04-30
MXPA02000117A (es) 2002-07-02
AU5222200A (en) 2001-01-31
EP1400519A1 (en) 2004-03-24
JP2003503403A (ja) 2003-01-28
PL352385A1 (en) 2003-08-25
IL147328A0 (en) 2002-08-14
HUP0201789A3 (en) 2003-12-29
EP1196410A1 (en) 2002-04-17
HK1045998A1 (en) 2002-12-20
HRP20080390A2 (en) 2008-12-31
WO2001000615A1 (en) 2001-01-04
KR20020000815A (ko) 2002-01-05
CN1358182A (zh) 2002-07-10
TR200500707T2 (tr) 2005-04-21
US7407969B2 (en) 2008-08-05
AU774829B2 (en) 2004-07-08
EE04592B1 (et) 2006-02-15
CN1171887C (zh) 2004-10-20
NO20016370L (no) 2001-12-27
IL147328A (en) 2007-06-03
PL200694B1 (pl) 2009-01-30
BG106288A (en) 2002-10-31
ES2215670T3 (es) 2004-10-16

Similar Documents

Publication Publication Date Title
EG24026A (en) Respiratory syncytial virus replication inhibitors
IL147327A0 (en) Respiratory syncytial virus replication inhibitors
HUP0201789A3 (en) Respiratory syncytial virus replication inhibitors
GB9924949D0 (en) Inhaler
AU2001278337A1 (en) Respiratory syncytial virus vaccine
ZA200110478B (en) Respiratory syncytial virus replication inhibitors.
AU2001275964A1 (en) Expiration date system
GB0114107D0 (en) Respiratory syncytial virus
AU4994800A (en) Plant-derived antigens against respiratory syncytial virus
EG22710A (en) Systems and methods for aerosolizing pharmaceutical formulations
GB0010995D0 (en) Respiratory aid
GB9923959D0 (en) Inhaler
GB9916283D0 (en) Inhaler
GB9913047D0 (en) Inhaler